drugset

drugset / Trial / NCT00170625

Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer

NCT00170625 ↗

Phase 1/2 Completed 28 enrolled North Eastern German Society of Gynaecological Oncology

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Compatibility of the topotecan therapy in combination with carboplatin.

Timeline

Start: 2004-06
Primary completion: 2005-08
Completion: —

Publications

Fotopoulou C, Karavas A, Trappe R, Chekerov R, Lichtenegger W, Sehouli J. Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO). Thromb Res. 2009 Nov;124(5):531-5. doi: 10.1016/j.thromres.2009.03.013. Epub 2009 May 8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Topotecan	Small molecule	0.75 mg/m2	—
Subject	Topotecan	Small molecule	1 mg/m2	—
Background	Carboplatin	Small molecule	—	—

Indications